Latest / Mesa News Today | 2 Min News | The Daily News Now!
Stockholm3 Blood Test Outperforms PSA
New research reveals a blood test called Stockholm3 that outperforms the standard PSA test at catching aggressive prostate cancer—spotting 90% of dangerous cases versus PSA’s 74%. The study tracked over 12,000 men for two years, showing Stockholm3’s ability to identify real threats without flooding patients with false alarms. While still in development and not yet FDA-approved in the U.S., this promising tool could revolutionize screening by reducing unnecessary biopsies and MRIs, catching deadly cancers earlier, and improving survival rates—all while easing patient anxiety and costs. Support…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.